First Horizon Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.53K | Sell |
2,850
-1,547
| -35% | -$1.92K | ﹤0.01% | 1916 |
|
|
2025
Q1 | $5.19K | Sell |
4,397
-580
| -12% | -$684 | ﹤0.01% | 1798 |
|
|
2024
Q4 | $9.11K | Buy |
4,977
+178
| +4% | +$326 | ﹤0.01% | 1639 |
|
|
2024
Q3 | $8.16K | Sell |
4,799
-151
| -3% | -$257 | ﹤0.01% | 1674 |
|
|
2024
Q2 | $6.78K | Hold |
4,950
| – | – | ﹤0.01% | 1676 |
|
|
2024
Q1 | $18.6K | Buy |
4,950
+778
| +19% | +$2.92K | ﹤0.01% | 1363 |
|
|
2023
Q4 | $40.9K | Buy |
4,172
+724
| +21% | +$7.1K | ﹤0.01% | 1032 |
|
|
2023
Q3 | $28.8K | Sell |
3,448
-1,192
| -26% | -$9.95K | ﹤0.01% | 1100 |
|
|
2023
Q2 | $61.7K | Sell |
4,640
-298
| -6% | -$3.96K | ﹤0.01% | 796 |
|
|
2023
Q1 | $57.2K | Buy |
4,938
+386
| +8% | +$4.47K | ﹤0.01% | 829 |
|
|
2022
Q4 | $37.2K | Buy |
4,552
+603
| +15% | +$4.93K | ﹤0.01% | 980 |
|
|
2022
Q3 | $22K | Buy |
3,949
+903
| +30% | +$5.03K | ﹤0.01% | 1203 |
|
|
2022
Q2 | $13K | Buy |
+3,046
| New | +$13K | ﹤0.01% | 1478 |
|
|
2022
Q1 | – | Sell |
-1,283
| Closed | -$25K | – | 2132 |
|
|
2021
Q4 | $25K | Buy |
+1,283
| New | +$25K | ﹤0.01% | 1194 |
|